<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3D101616-CA8D-47BE-95E3-A8D7CE62A02B"><gtr:id>3D101616-CA8D-47BE-95E3-A8D7CE62A02B</gtr:id><gtr:name>North West University</gtr:name><gtr:address><gtr:line1>Potchefstroom Campus</gtr:line1><gtr:line2>Private Bag X6001</gtr:line2><gtr:postCode>2520</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6020EDD4-B3F4-4D08-80DE-E387DD4EB8AB"><gtr:id>6020EDD4-B3F4-4D08-80DE-E387DD4EB8AB</gtr:id><gtr:name>University College London Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C"><gtr:id>CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C</gtr:id><gtr:name>Peninsula College Of Medecine and Dentistry Foundation</gtr:name><gtr:address><gtr:line1>Harscombe House 1 Darklake View
Estover</gtr:line1><gtr:city>Plymouth</gtr:city><gtr:postCode>PL6 7TL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3D101616-CA8D-47BE-95E3-A8D7CE62A02B"><gtr:id>3D101616-CA8D-47BE-95E3-A8D7CE62A02B</gtr:id><gtr:name>North West University</gtr:name><gtr:address><gtr:line1>Potchefstroom Campus</gtr:line1><gtr:line2>Private Bag X6001</gtr:line2><gtr:postCode>2520</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6020EDD4-B3F4-4D08-80DE-E387DD4EB8AB"><gtr:id>6020EDD4-B3F4-4D08-80DE-E387DD4EB8AB</gtr:id><gtr:name>University College London Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C"><gtr:id>CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C</gtr:id><gtr:name>Peninsula College Of Medecine and Dentistry Foundation</gtr:name><gtr:address><gtr:line1>Harscombe House 1 Darklake View
Estover</gtr:line1><gtr:city>Plymouth</gtr:city><gtr:postCode>PL6 7TL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/85D807DF-0780-4EA3-B61C-036EBF025B49"><gtr:id>85D807DF-0780-4EA3-B61C-036EBF025B49</gtr:id><gtr:firstName>Huw</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100643"><gtr:id>DE8F77D1-B60A-4650-8834-360534CDCC0C</gtr:id><gtr:title>Determining the genetic aetiology of early onset Parkinson's disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100643</gtr:grantReference><gtr:abstractText>Parkinson?s disease (PD) is a common degenerative brain disease in which loss of nerve cells leads to slowness of movement, tremor, stiffness and difficulty walking. As the disease progresses some patients develop dementia and become increasingly incapacitated. There are no treatments that reverse the damage to the brain or halt the disease process. Some younger patients with PD have autosomal recessive genetic disease. We all carry two copies of about 20,000 genes. In autosomal recessive disease two faulty copies of a gene lead to loss of gene function. In this form of genetic inheritance there is usually no increased risk of disease for children or parents of affected patients. To date three genes have been identified for autosomal recessive PD which have been important in leading to new genetic tests for PD, and in helping us to understand the disease processes. We suspect that PD is a heterogeneous disease, with many different processes leading to a similar clinical syndrome. The main goal of this work will be to identify new disease genes which will enable more accurate genetic testing for this condition, the appropriate targeting of new treatments to the correct patients and the development of new treatments in cell and animal models. In our work we have shown that among early onset PD patients there is strong evidence for the existence of further autosomal recessive genes and we have identified a set of 71 early onset PD patients (EOPD) who are likely to have this type of gene change, causing PD. We will identify new genes that cause PD by detailed study of these 71 patients using a recently developed technique called next generation sequencing. This allows a rapid scan for gene changes across all 20,000 genes in the human genome. This will identify a series of possible new genes. The second stage will be to try to confirm these findings in a large representative set of 1300 EOPD patients. The identification of new genes for PD will lead to new diagnostic tests, a better understanding of various forms of PD and the development of new cell and animal models for the disease. This will allow the development of new treatments that we hope will improve the outlook for people with PD.</gtr:abstractText><gtr:technicalSummary>Although Parkinson?s disease (PD) is a common age dependant neurodegenerative condition about 5% of all PD patients develop disease before the age of 50 (Early onset PD ? EOPD). Three autosomal recessive EOPD genes (parkin, PINK1 and DJ1) have been identified and their discovery has led to new diagnostic tests and insights into the pathogenesis of PD. Many groups have developed cell and animal models of PD based on these genes. There is compelling evidence that there are further autosomal recessive (AR) genes to be identified for EOPD, based on segregation analyses, comprehensive mutation screening and on our own work on homozygosity mapping. We have ascertained over 250 UK patients with EOPD and are members of the International Consortium for PD Genomics (ICPDG), which has collated samples and data on 1400 EOPD patients. Previous gene identification has been based on linkage in known consanguineous families. The advances in next generation sequencing (NGS) mean that we are now in a position to resolve the genetic architecture of EOPD, in a ?linkage-free? approach. Our work indicates that a two-stage approach will be the most efficient. We have demonstrated an excess of genomic homozygosity in EOPD, largely contributed to by a subset of 71 patients in our sample set who carry an 8 Mbp or longer run of homozygosity (ROH). In stage 1 we will examine the entire exome of each of these 71 patients to identify genes that contain a homozygous rare putative loss of function (LOF) mutation. We anticipate that this will identify approximately 20 candidate genes. In stage 2 the exonic sequence of each of these 20 genes will be screened for homozygous and compound heterozygous mutations in the remaining 1300 EOPD patients and 4000 controls (via the UK10K and 1000 genomes projects). Case control analysis of rare bi-allelic LOF mutations will identify which loci are new AR PD genes. This two-stage approach provides a powerful (power 0.99) and efficient approach to identifying new genes for EOPD. Identifying the genetic basis of PD in these patients is the first step in understanding disease heterogeneity and appropriately designing and targeting disease modifying therapies. This work will also inform the design and provision of new diagnostic genetic screening panels.</gtr:technicalSummary><gtr:fund><gtr:end>2015-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-07-09</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>902052</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Institute of Medical Genetics, University Hospital of Wales, Cardiff</gtr:description><gtr:id>C7DCDE07-E742-47B2-AECC-AB460A075CBF</gtr:id><gtr:impact>Our collaboration with the NHS Medical Genetics Service in Cardiff has led to the development and service provision of NHS based diagnostic and predictive testing for mutations in parkin and LRRK2
We have also published on other Mendelian conditions including Alzheimer disease, Fronto-temporal dementia and Amyotrophic lateral sclerosis</gtr:impact><gtr:outcomeId>D276CBBD869-1</gtr:outcomeId><gtr:partnerContribution>identification of potential research collaborators via users of the NHS service</gtr:partnerContribution><gtr:piContribution>In collaboration with the NHS Medical Genetics Service in Cardiff we have worked on the development and provision of genetics testing for parkin and LRRK2 - we have worked on the preparation for the submission to the UK Genetic Testing Network</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Plymouth - PD-STAT study</gtr:description><gtr:id>AD391A52-3D7D-45DE-B1DB-FA171094C003</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>56d41f6ea44853.91721834-1</gtr:outcomeId><gtr:partnerContribution>Collection of DNA samples and clinical data</gtr:partnerContribution><gtr:piContribution>The study investigates the potential of simvastatin to slow or halt the progression of Parkinson's disease. This research team has contributed by organising the addition of a genetics sub-study to the main clinical trial.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International Consortium for PD Genetics</gtr:description><gtr:id>585780CB-5BB3-49F5-A37D-073C97DD439E</gtr:id><gtr:impact>Meta-analysis of data reveals 11 loci for late onset PD; manuscript submitted to Lancet
Part of this collaboration includes the collaborative analysis of Copy Number Variants and Homozygosity Mapping in Early Onset PD within the same consortium</gtr:impact><gtr:outcomeId>pFbnpW5Bane-1</gtr:outcomeId><gtr:partnerContribution>Pooling of data - allowing large scale analysis of homozygosity in PD and identification of novel loci for late onset PD</gtr:partnerContribution><gtr:piContribution>Collaboration with Holland, Germany, France and US in the further analysis of Genome Wide Association Studies in PD</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with National Institute of Health Research (NIHR)</gtr:description><gtr:id>685982A4-D4EE-43CD-8336-2D755F4B6EA8</gtr:id><gtr:impact>This collaboration has resulted in increased recruitment and improved delivery to both the 100,000 Genomes Project, the Parkinson's Families Project, and other studies within the NIHR portfolio. Staff from both Genomics England Project and NIHR CRN collaborate closely to optimise recruitment, and can be trained to recruit in a variety of studies.

The NIHR Research Capability Funding has also enabled extension of the Research Assistant post, allowing recruitment to continue into 2017.</gtr:impact><gtr:outcomeId>587ce5dbca6165.62038118-1</gtr:outcomeId><gtr:partnerContribution>The NIHR Clinical Research Network have provided nurse and staff support for recruitment at hospitals around the UK. In addition, the NIHR have supported staff salary costs for the research assistant position at the Royal Free Hospital by awarding Research Capability Funding in 2016 and 2017.</gtr:partnerContribution><gtr:piContribution>Our research team has contributed to NIHR recruitment by recruiting to the Parkinson's Families Project, which is adopted on the NIHR portfolio of studies. Increased recruitment assists with allocation of funding to sites and networks within the NIHR.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Chromosome 9 MND</gtr:description><gtr:id>50108B1B-0895-4246-888B-441D9DB2B1B8</gtr:id><gtr:impact>Publications/filing the patent/NHS for MND developed/Follow on grant from MND Association/talk for patients' group</gtr:impact><gtr:outcomeId>sPxjFVb7bUm-2</gtr:outcomeId><gtr:partnerContribution>Genetic analysis</gtr:partnerContribution><gtr:piContribution>Clinical/pathological/cell biology/genetic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>9DB3C608-EE6E-40AB-B9D4-12BFA5981C9B</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:outcomeId>56d421a516a979.91203860-4</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neuroscience and Psychology</gtr:department><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>67B8C6A2-0654-4B90-979C-546344F99BAD</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:outcomeId>56d421a516a979.91203860-1</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>UK PD WTCCC2 Consortium</gtr:description><gtr:id>ED752DFA-3F1B-4317-8C04-B5DB0400ECCF</gtr:id><gtr:impact>Obtained follow on funding from Parkinson's disease society for replication and data analysis 
Primary UK PD GWAS paper - published in Human Molecular Genetics</gtr:impact><gtr:outcomeId>2EEBB522C9D-1</gtr:outcomeId><gtr:partnerContribution>We have collaborated in the whole genome genotyping of approximately 2000 UK Parkinson's disease subjects. The data derived from this is being used to supplement the primary analysis in the MRC grant and this has lead on to further follow on funding for the consortium from the Parkinson's disease society.</gtr:partnerContribution><gtr:piContribution>We have contributed samples from PD patients and are collaborating in the analysis of autozoygosity, copy number variants and gene pathway analysis in these datasets.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration wth Genome England Limited</gtr:description><gtr:id>8765ADBC-89B3-4F19-AA88-81AB9B109CC5</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>5461bc636d0859.88746793-1</gtr:outcomeId><gtr:partnerContribution>Family recruitment - will involve analysis of data and correlation with clinical and para-clinical measures</gtr:partnerContribution><gtr:piContribution>Recruitment of Early Onset PD families for whole genome sequencing</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peninsula College of Medicine &amp; Dentistry</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Plymouth - Molecular Genetic Studies of Neurodegenerative Disorders</gtr:description><gtr:id>B4B18855-AEBC-4506-9C78-5499CD9D3F46</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d41e387ecd48.78888069-1</gtr:outcomeId><gtr:partnerContribution>Recruitment and collection of samples for over 2000 participants within the UK.</gtr:partnerContribution><gtr:piContribution>A collaborative study involving the collection and storage of DNA and protein samples from patients in comparison to participants without Parkinson's. This research team contributed through genotyping of samples and follow up of participants to collect key clinical data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>43C72114-6A6D-47AB-8D26-B835251625DE</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:outcomeId>56d421a516a979.91203860-3</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>Unknown</gtr:country><gtr:department>Birmingham Clinical Trials Unit</gtr:department><gtr:description>Collaboration with Birmingham PD-MED</gtr:description><gtr:id>825B3C93-6128-4A82-93C5-8A5855211889</gtr:id><gtr:impact>None so far.</gtr:impact><gtr:outcomeId>56d41ca8112079.31057892-1</gtr:outcomeId><gtr:partnerContribution>Approximately 2000 participants recruited through more than 80 neurology and care of the elderly units throughout the UK.</gtr:partnerContribution><gtr:piContribution>A collaborative study involving large randomised assessment of the relative clinical and cost-effectiveness of classes of drugs for Parkinson's disease. Sharing of samples and data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NIAGADS data request</gtr:description><gtr:id>91C4112B-A568-41DC-9EBD-ADB0967258FC</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d425c6548e74.17973780-1</gtr:outcomeId><gtr:partnerContribution>Access to large datasets of human genomic and phenotypic data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples.</gtr:partnerContribution><gtr:piContribution>Analysis of combined clinical data from the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Neurogenetics</gtr:department><gtr:description>Chromosome 9 MND</gtr:description><gtr:id>F5BDE53D-6686-455F-9CA1-34AB7CDC4E7F</gtr:id><gtr:impact>Publications/filing the patent/NHS for MND developed/Follow on grant from MND Association/talk for patients' group</gtr:impact><gtr:outcomeId>sPxjFVb7bUm-1</gtr:outcomeId><gtr:partnerContribution>Genetic analysis</gtr:partnerContribution><gtr:piContribution>Clinical/pathological/cell biology/genetic analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>North-West University</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>South African PD sample sharing</gtr:description><gtr:id>CF635FE6-1B8D-40D6-9251-C614CB62FE02</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d423824b7665.60463958-1</gtr:outcomeId><gtr:partnerContribution>Collection and sharing of DNA and clinical data from early onset and familial Parkinson's/ parkinsonism patients.</gtr:partnerContribution><gtr:piContribution>Genotyping of PD samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>University College London Hospitals Charity (UCLH)</gtr:department><gtr:description>Collaboration with NHS Neurogenetics UCLH</gtr:description><gtr:id>B26DD843-4E23-416C-9342-BAC78541C51B</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5461bbab278db6.54619109-1</gtr:outcomeId><gtr:partnerContribution>Provision of NHS genetic testing</gtr:partnerContribution><gtr:piContribution>Developing NHS testing for PD and following up on NHS patients</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PROBAND</gtr:description><gtr:id>738DB03C-EBC5-4C1A-96AB-87F88449931A</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>Lgm9M4tiBiZ-1</gtr:outcomeId><gtr:partnerContribution>Organisation and collection of samples over 50 sites in UK</gtr:partnerContribution><gtr:piContribution>A collaborative study of the genetics of Parkinson's disease following 2240 UK patients with PD. Arranging and carrying out genotyping.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>6BC1A3AF-A17E-4F66-BD82-C3C4264B08AE</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:outcomeId>56d421a516a979.91203860-2</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Progressive Supranuclear Palsy Research Event (Durham)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1DA9E934-A3A1-46C4-9C1A-8E5ADE013A99</gtr:id><gtr:impact>The psychology department at Durham University, in collaboration with South Tees NHS Trust, organised the event for academics, clinicians, patients and carers to discuss research relating to PSP. The all-day event involved presentations from healthcare professionals and the PSP network on topics including what's new in PSP, symptom control, and care planning. There were also workshop sessions to develop new research ideas.</gtr:impact><gtr:outcomeId>56d4468e6e0c02.06090373</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk for Frontotemporal Dementia (FTD) UK meeting 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>42543DEE-A99F-4FE6-A401-5E6E3A2D59A7</gtr:id><gtr:impact>The day presented exciting updates about current and future research for both frontotemporal dementia (FTD) and overlapping conditions such as progressive supranuclear palsy (PSP) and motor neuron disease (MND). Talks covered: brain imaging techniques, genetics, cell function, drug trials and clinical practice.</gtr:impact><gtr:outcomeId>587cefbc555225.59209799</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ftdtalk.org/ftd-uk-2016-latest-ftd-research-across-uk/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CBD Solutions Scientific Meeting (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99BC755E-DD97-4520-928F-497BFCA4517F</gtr:id><gtr:impact>The meeting, organised by CBD Solutions, was attended by neurologists and academics and included discussion on:
- Mechanisms of CBD (pathology, genetics, GWAS/tau)
- Models of CBD
- Biomarkers of CBD and cohorts
- Clinic assessments</gtr:impact><gtr:outcomeId>56d453e99a5df7.67154099</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Positive Steps in Parkinson's</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0E2392AA-625B-4580-8328-E2E6354AAAB5</gtr:id><gtr:impact>The purpose of the meeting was to share practical skills that will enable physicians and nurses to deliver the best care for Parkinson's patients. Along with some of the top Parkinson's experts, the group discussed the latest research and techniques, shared best practice and debated interesting case studies.</gtr:impact><gtr:outcomeId>56d433c32a5011.08925948</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.parkinsonsps.com/home</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Consortium on SOD and ALS (Liverpool)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CB085427-911A-4776-886B-C87F4455D90F</gtr:id><gtr:impact>Invited talk on genetics of MND at International Consortium on SOD and ALS, held at the University of Liverpool.

Shared knowledge to design better-informed experiments to understand the rare, inherited SOD1 form of MND</gtr:impact><gtr:outcomeId>5450e023702700.61548626</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists annual meeting 2016 (Brighton)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EA9ADEA3-A357-4B46-B7D6-81CF162F4EB9</gtr:id><gtr:impact>Members of the research team attended the conference and presented posters to clinicians, researchers and trainees.</gtr:impact><gtr:outcomeId>587de1a4be2390.36887324</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.theabn.org/events/forthcoming/abn-annual-meeting-2016.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust advanced course in Molecular Neurology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FA505EEF-01C2-4E92-BB38-10E4EC6D73AC</gtr:id><gtr:impact>Invited speaker to Wellcome Trust Advanced course in Molecular Neurology

unknown</gtr:impact><gtr:outcomeId>n1H7GjrnShc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Masterclass (Bristol)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C969DDD8-3958-445C-A200-4BA794BAAB1D</gtr:id><gtr:impact>Invited speaker at Parkinson's Academy Masterclass, a teaching course for consultants and final year SpR's, GPWSI, Associate Specialists and Staff Grade Physicians.

The course advanced attendees' understanding of Parkinson's disease and related movement disorders through taught sessions, worked examples and mentorship.</gtr:impact><gtr:outcomeId>544fcacbece647.05488297</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.parkinsonsacademy.co.uk/</gtr:url><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ABN Movement Disorders Special Interest Group (ABN MD SIG) meeting (Cambridge)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E52E91D-3D6D-43CE-A6C0-AAB35B7A4966</gtr:id><gtr:impact>The inaugural ABN Movement Disorders Special Interest Group (ABN MD SIG) meeting took place on the 15th and 16th of January 2015 at Downing College, Cambridge. The programme was organised by Professor David Burn (Newcastle) and Dr Paul Worth (Cambridge) and included several internationally renowned speakers. The morning session aimed to summarise current topics that have furthered our understanding in the pathophysiology of movement disorders. The event including discussion on topics such as GBA mutations, the role of alpha-synuclein, novel MRI techniques, recent developments in gene sequencing technologies, neuroprotection studies and case presentations undertaken by Prof Huw Morris.</gtr:impact><gtr:outcomeId>56d459d1dcd352.15394823</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.acnr.co.uk/2015/06/abn-md-sig-conference/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at International Parkinson's Disease and Movement Disorders Conference (Sydney)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4B0A73A3-C47D-4D99-9C76-F3833ADA6160</gtr:id><gtr:impact>The Conference brought together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Parkinson's Disease and Movement Disorders. It provided a forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Parkinson's Disease and Movement Disorders.

Unknown</gtr:impact><gtr:outcomeId>544fc3188adf41.20117225</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Younger Parkinsons Network Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1C577BB0-7FB3-4F8B-8CEA-784D2C8E3EF6</gtr:id><gtr:impact>Presented on our research to UK Younger onset Parkinson's group Stratford

Not Known</gtr:impact><gtr:outcomeId>iJJmGD9nKaJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PD-STAT/ Cure Parkinson's Trust meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2C4EC765-B3B2-4D0B-A338-AB2EE4945AC5</gtr:id><gtr:impact>A joint event was organised by the Cure Parkinson's Trust and Plymouth University Clinical Trials unit. The purpose of the meeting was to outline the aims and processes of the PD-STAT (Simvastatin as a neuroprotective treatment for Parkinson's disease) clinical trial to patients and investigators. Members of our research team delivered presentations on linked Parkinson's research studies and made contact with potential participants. This event successfully generated interested in the PD-STAT study and related Parkinson's research studies.</gtr:impact><gtr:outcomeId>56d4491b144539.30624348</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IBRO-ARC Egypt Neuroscience School (Cairo)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0DCF3630-033C-4C1D-8E6B-A3AB24FD0D14</gtr:id><gtr:impact>Invited talk on the genetics of Parkinson's Disease and diagnosis of movement disorders at IBRO-ARC Egypt Neuroscience School on &amp;quot;Epigenetics and neurological disorders: from bench side to bedside (PD in Focus)&amp;quot;.

Unknown</gtr:impact><gtr:outcomeId>544fd225c46c71.65262745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Younger People Living With Dementia organised by UCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A24F633-FAFF-4F94-91B5-E7B7553781C0</gtr:id><gtr:impact>A joint conference organised by University College London and the Journal of Dementia Care was held in November 2015. The focus of the meeting was joined up working between psychiatry, neurology and clinical genetics to improve diagnosis.</gtr:impact><gtr:outcomeId>56d43c9debace5.15000897</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.careinfo.org/young-dementia-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Conference, MA Healthcare (London) 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7CB221E4-EE8C-4F99-974F-318FAE02EEF7</gtr:id><gtr:impact>Prof Morris presented a talk at the MA Healthcare Parkinson's conference. Audiences had the opportunity to learn about distinguishing the different Parkinsonisms, update their knowledge on treatments and therapies including exercise and deep brain stimulation, explore the potential for novel treatments in Parkinson's, hear a first-hand carer experience of Parkinson's management strategies, and share and exchange ideas with the leading practitioners in the field.</gtr:impact><gtr:outcomeId>587ddec16f0988.05428486</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mahealthcareevents.co.uk/public/MAH%20Parkinsons_2016_4pp%20WEB2.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Parkinson's UK Research conference: the Parkinson's Families Project</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4658F26-2C62-4D42-AEA5-BE9F5A6D3178</gtr:id><gtr:impact>Our research assistant presented a poster at the Parkinson's UK Research Conference 2016, presenting baseline data from the Parkinson's Families Project.</gtr:impact><gtr:outcomeId>587cf1d8122a23.48424896</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Genome Campus Molecular Neurodegeneration course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F119B53A-2228-49DE-A668-AF2615C91C59</gtr:id><gtr:impact>This course provided an overview of the molecular basis of neurodegeneration and the development of treatment strategies to combat neurodegenerative disorders. The programme focused on several disorders including Alzheimer's disease, Parkinson's disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes. Participants gained an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies. The programme was aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchers.</gtr:impact><gtr:outcomeId>587ceb5d5dbfc4.19105578</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://coursesandconferences.wellcomegenomecampus.org/events/item.aspx?e=606</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICOSA Meeting - ALS/FTD</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9E2B94AC-C04A-420B-9349-347EE8B6555F</gtr:id><gtr:impact>Invited speaker at meeting on Chromosome 9

unknown</gtr:impact><gtr:outcomeId>FmfBhqAQoEp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MND Meeting</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B6C13B83-9C52-4226-B0B2-0D3F9D7DBF5D</gtr:id><gtr:impact>UK consortium for Chromosome 9

unknown</gtr:impact><gtr:outcomeId>bmCzM7w6KsK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on early-onset Parkinson's Disease genetics at UK GTN meeting (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E02EFCC0-3D25-49FC-BF9C-F82351E7C48C</gtr:id><gtr:impact>65 participants attended the conference, including consultant neurologists, specialist registrars in neurology and interested general paediatricians.

Through the lectures and discussions, it was highlighted that:
? The efficiency of genetic testing could be increased if there was a shift from serial genetic testing to genetic panel testing and potentially in the future to exome-sequencing. 
? There was considerable evidence presented that for conditions which had treatment options available, early genetic testing assisted in the early
intervention and management of the condition with better clinical outcomes. However, there remain a significant number of conditions for which a treatment is not available despite access to genetic tests for diagnosis. Nevertheless, often, early diagnosis of a neurological condition through
genetic testing, using the UKGTN testing criteria, may facilitate management interventions such as accurate genetic counselling. 
? Additional benefits of genetic testing include early and accurate diagnosis, planning of appropriate clinical care, and advice on prognosis. 
? Certain challenges need to be considered in using genetic testing for neurological conditions including access, cost limitations and incidental findings. It is apparent that with discoveries of new genetic contributions to clinical conditions, new clinical pathways and genetic tests will need to be developed. The details of these in turn will need to be disseminated to relevant clinical specialists in a timely manner.

Unknown</gtr:impact><gtr:outcomeId>544fbbbe6c96f7.32614927</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK website information for the Parkinson's Families Project</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2C98EA6-E311-4F69-85DB-5980DCD88AEA</gtr:id><gtr:impact>Parkinson's UK have provided summary information about the Parkinson's Families Project on their website. Many potential participants have contacted the research team as a result of seeing this page or hearing about the study through Parkinson's UK&amp;gt;</gtr:impact><gtr:outcomeId>587e1ab59771b1.23815833</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://www.parkinsons.org.uk/content/take-part-parkinsons-research-list-uk-studies</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Y Move&quot; talk (Leeds)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0772C5B6-BD9B-4618-843F-667271D4FE7B</gtr:id><gtr:impact>Presented talk at &amp;quot;Y Move&amp;quot; in Leeds.</gtr:impact><gtr:outcomeId>587ced7563f222.02340914</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview reviewing Michael J Fox's book 'Lucky Man'</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5FDD137C-4097-43F6-A2C5-0B8B0581A9A3</gtr:id><gtr:impact>Radio interview on Practical Neurology with Phil Smith. Discussed early-onset Parkinson's, impact of diagnosis and reception of Michael J Fox's memoir.

Unknown</gtr:impact><gtr:outcomeId>5450b639352d26.00413838</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MA Healthcare Parkinson's 2015 conference (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E72B4169-0F75-4606-AEC1-2DB3593A4896</gtr:id><gtr:impact>The conference, organised by MA Healthcare in collaboration with the British Journal of Hospital Medicine and the British Journal of Neuroscience Nursing, was attended by a variety of health and social care professionals involved in the management of Parkinson's, including: neurologists, geriatricians, psychiatrists, neurosurgeons, GPs, community mental health teams, nurse specialists, allied health professionals, and trainees. Attendees benefited from presentation and discussion from leading practitioners and researchers, covering topics such as:
- Distinguishing different Parkinsonisms (talk presented by Prof Morris)
- Pre-diagnostic markers of Parkinson's
- Hospitalisation in Parkinson's
- Advances in PET imaging
- Practical strategies for Parkinson's management
- Pharmacological management
- Exercise
- Surgery and Deep Brain Stimulation
- Depression and anxiety
- Palliative care</gtr:impact><gtr:outcomeId>56d44ccb7a16b7.20953973</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of the DVLA Honorary Medical Advisory Panel on Driving and Disorders of the Nervous System (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7F35D745-2471-4F7D-B0DE-A9E262EF2A95</gtr:id><gtr:impact>Members of the Honorary Medical Advisory Panel for the DVLA met and discussed:
- Extended period licensing
- Sleep apnoea and impacts
- Regulations regarding isolated seizures
- Visual inattention
- Sudden and disabling events following head injury</gtr:impact><gtr:outcomeId>56d455c6d103f2.39861710</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Molecular Neurology and Therapeutics course (Cambridge/New York)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76E97330-3124-4A30-BA0F-92BD5A0E59B6</gtr:id><gtr:impact>Invited speaker at the Molecular Neurology and Therapeutics course, organised by Wellcome Trust

Taught attendees the latest concepts and methodologies associated with the study of human neurological disorders including Parkinson's disease. Generated discussion about the strengths and weaknesses of the accumulated experimental evidence underlying our current understanding of neurological diseases and how this knowledge can be applied to developing therapeutic approaches.</gtr:impact><gtr:outcomeId>5450d7bc6e5d68.03022501</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edgware Research day: Parkinson's: Knowledge, Power, Treat. A vision for the future</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>737EFE70-84CB-4119-A12E-3C9EFC09F601</gtr:id><gtr:impact>This research day was targeted towards local patients at Edgware Community Hospital and Central London Community Healthcare NHS Trust. Researchers and patients presented talks on Parkinson's research and patient experiences. Talks were supplemented by panels, networking and Question and Answer sessions.</gtr:impact><gtr:outcomeId>587cf3352da2a3.50292083</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Southampton</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>37BAD379-3BD9-4705-B698-6EFFA9698DAD</gtr:id><gtr:impact>Delivered a talk at Southampton Hospital</gtr:impact><gtr:outcomeId>56d43e541e5b75.71634119</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dendron UK PD Clinical Studies Group</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EB0A78DC-7262-418D-8265-17B7F3878625</gtr:id><gtr:impact>Chair of expert group - developing new research in PD

unknown</gtr:impact><gtr:outcomeId>Y7mYP8XsMQj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL- DZNE- ICM meeting (Paris)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5885828E-80F6-4092-BEAA-D90643C28C0B</gtr:id><gtr:impact>Attended a collaborative meeting between Institute du Cerveau et de la Moelle epiniere (ICM), Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZM) and University College London (UCL). Attendees discussed:
- Translational models of PD
- Neurophysiology, neuropsychology, motor and non-motor symptoms in PD
- Biomarkers, multimodal, methodology of PD
- Brain imaging in PD
- Neuropathology and mechanisms of neurodegeneration in PD
- Genetics and molecular aspects of PD
- Therapeutic trials in PD</gtr:impact><gtr:outcomeId>56d44339439489.34593253</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the UCL Basal Ganglia Club (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>59301125-7E5A-4E15-A3F3-58B3F0A6B700</gtr:id><gtr:impact>Presented talk at Basal Ganglia Club to clinicians and researchers.</gtr:impact><gtr:outcomeId>587e14a5769532.93724845</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BritMODIS 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4034953B-1EAE-41D9-AD8B-439018BBDACC</gtr:id><gtr:impact>The meeting provided a forum for education in movement disorders and was organized by the British Geriatrics Society Movement Disorders Section, Association of British Neurologists Movement Disorders Special Interest Group, Parkinson's Disease Nurse Specialist Association and Parkinson's UK. The meeting highlighted current clinical practice and provided a platform to present research outcomes and showcase successful service delivery. 

This event was organized for healthcare professionals working in the field of movement disorders. The day provided a forum for scientific discussion and clinical updates and enables a multidisciplinary audience of healthcare professionals to share their experiences of best clinical practice.</gtr:impact><gtr:outcomeId>56d43492c5bba3.20247718</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.eiseverywhere.com/ehome/152739</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cure Parkinson's Trust Research Meeting 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6E4E340B-F23A-4DC9-969D-A50F92979E51</gtr:id><gtr:impact>Two research team members delivered brief presentations at the Cure Parkinson's Trust research meeting, to approximately 100 patients, carers and key personnel within Cure Parkinson's Trust. Information about current research trials and planned studies was presented.</gtr:impact><gtr:outcomeId>587ce9b79eeb70.26245424</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists - fundraising and council</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1F9D6F50-69A5-49BB-92B0-75AF45332FA8</gtr:id><gtr:impact>Fundraising event and council meeting of the Association of British Neurologists</gtr:impact><gtr:outcomeId>56d4361ae2c766.57603132</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Committee - PSP</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5E4BBDA4-AF54-4664-89AD-1AF060A162EF</gtr:id><gtr:impact>Developing Care Standards for PSP

http://www.pspeur.org/care_pathway/</gtr:impact><gtr:outcomeId>C9cF4DYnVpF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Families Projects website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A5FAF3EB-CFD8-49BF-A2AD-8FAD0306C613</gtr:id><gtr:impact>The PFP website is designed for members of the public, patients and participants to receive essential information about the research project. The website features comments and experiences of patients with Parkinson's, and information on how to get in contact with the research team.</gtr:impact><gtr:outcomeId>587e19fba92948.62055073</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.parkinsonsfamiliesprojects.com/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK Royal College of Physicians Research Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30CAB6F0-A81C-44C2-B07E-078CA7CE895D</gtr:id><gtr:impact>This event was organised by Parkinson's UK for patients and the general public. The theme of the presentation was: Parkinson's and Genetics - Unlocking the next generation of treatments. Researchers discussed:
Rare changes to our genes that can cause the condition
How genetics research has progressed in other neurological conditions and how we can emulate this for Parkinson's
The different areas of treatments that are emerging in the field of genetics</gtr:impact><gtr:outcomeId>56d4393d6d6986.52382943</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Conference on Frontotemporal Dementias (Manchester)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1F8A61B5-98A3-47DC-8ABA-D207253BBDAD</gtr:id><gtr:impact>Presented paper on C9ORF72.

Clinicians and researchers exchanged knowledge about the latest developments in FTD.</gtr:impact><gtr:outcomeId>544fce4c5df940.39558283</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>paper presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of Society of Physicians in Wales (Port Meirion, Wales)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>918ECDD2-555C-4450-BC8D-8768EC9F8DC3</gtr:id><gtr:impact>Invited speaker, presented a talk 'Neurogenetics in Gwent - Chromosome 9 linked ALS'.

Unknown</gtr:impact><gtr:outcomeId>5450dc22d06971.64967902</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Positive Steps in Parkinson's Disease (Manchester)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>24BDBF0E-0479-4443-94F2-515DCFBF2941</gtr:id><gtr:impact>Invited speaker, presented talk on 'Top tips for the management of the patient with atypical parkinsonism'.

Unknown</gtr:impact><gtr:outcomeId>544fc7bf7efcc9.81209211</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar on early onset PD at the Walton Centre (Liverpool)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7499C82B-CD6F-40CE-BAA1-DAEE119958E8</gtr:id><gtr:impact>Invited talk on early onset Parkinson's Disease as part of the departmental seminar series.

Share information</gtr:impact><gtr:outcomeId>544fd095314874.63371220</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with BBC News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACEEFA90-A2C0-4AE0-8962-44E7D6FBFE7D</gtr:id><gtr:impact>http://www.bbc.co.uk/news/uk-wales-south-east-wales-15005209

unknown</gtr:impact><gtr:outcomeId>kQXvWapLByF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Neuroscience meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>94B10840-0120-4928-BF10-2843B3D70567</gtr:id><gtr:impact>Delivered presentation at Cardiff University Neuroscience meeting</gtr:impact><gtr:outcomeId>56d43d63a47514.11974303</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Movement Disorders Congress 2016 (Berlin)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5C30D1E2-CEED-401D-B9D6-1E7B39E733AC</gtr:id><gtr:impact>Members of the research team attended the Movement Disorders Congress in Berlin and presented posters to communicate research findings.</gtr:impact><gtr:outcomeId>587ddfd5c4b5e7.35944978</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mdscongress2016.org/Congress-2016.htm</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PD Genetics update for British Movement Disorders Group (BritMODIS) meeting (Birmingham)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>89C4E681-75F8-4644-BC5C-61729A35FDAC</gtr:id><gtr:impact>The meeting was attended by neurologists, geriatricians and PD nurse specialists, which generated good discussion about multidisciplinary working in Parkinson's Disease.

Sharing information among clinicians.</gtr:impact><gtr:outcomeId>544fbfe82c3ef6.34899495</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Molecular Neurodegeneration course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8CF44151-56FE-40E9-BA50-1766AEA2B5C3</gtr:id><gtr:impact>This highly-regarded course provided a cutting edge examination of the molecular basis of neurodegeneration and the development of treatment strategies. Many parallels are evident between different neurodegenerative diseases and this course highlighted and discussed, in detail, the common themes across neurodegenerative processes. Course participants gained an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental evidence and how this knowledge can be applied to develop therapies.

Course topics included:
? Pathological events in human neurodegeneration
? Development of therapeutic approaches
? Genetic variation in inherited and sporadic disease
? Role of pathogenic proteins 
? Use of in vivo models to study neurological pathogenesis
? The application of high content approaches
? Genome editing: methods and applications</gtr:impact><gtr:outcomeId>56d43b555d1bf3.50547232</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Driver and Vehicle Licensing Agency Medical Advisory Panel 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>07F2EFE5-2929-4CB3-9431-72B14DB31908</gtr:id><gtr:impact>Prof Morris attended the meeting of the Secretary of State for Transport's Honorary Medical Advisory Panel on driving and disorders of the nervous system. Decisions were made and advice was provided regarding driving and licensing regulations related to neurological conditions.</gtr:impact><gtr:outcomeId>587e17b6858e12.43682117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CurePSP Symposium (San Francisco)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FD675AD7-8605-4204-A4BB-6AE53F88EA53</gtr:id><gtr:impact>CurePSP conducts an annual International Research Symposium that brings together international investigators to hear about and discuss the latest advances in prime of life neurodegeneration including PSP, CBD, MSA and related diseases. The Symposium highlighted research by CurePSP grantees. The Research Symposium also assisted the CurePSP Scientific Advisory Board (SAB) in identifying work of exceptional promise, which may then be considered for additional funding. Presentations covered: cell biology research, genetics research, clinical trials, diagnostic criteria and therapeutic opportunities.</gtr:impact><gtr:outcomeId>587cf487f23a44.12604831</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDS-ES Strategic Planning Retreat (Lisbon)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6B76DA1C-10EE-4021-95B1-BF85896F45ED</gtr:id><gtr:impact>Strategic planning meeting organised by the Movement Disorder Society (European section) held in Lisbon, January 2016</gtr:impact><gtr:outcomeId>56d4379fd16185.82073116</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>YPN Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8918FEBB-6B6F-4E75-AFA6-CD2CEA33DF4F</gtr:id><gtr:impact>Piece on our research for Younger Parkinson's Group Newsletter

Not Known</gtr:impact><gtr:outcomeId>NZ1JUrrD5cN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual meeting of the Association of British Neurologists (Cambridge)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5D6009DF-8ADA-4AB5-AB05-2EA9E25E1271</gtr:id><gtr:impact>Invited talk on current genetic approaches to diagnosis, and emerging faster and less expensive methods of genomic analysis. 615 delegates, including medical students, junior doctors and non-physicians, attended lectures and teaching sessions.

Audience generated positive feedback and reported being stimulated in their knowledge of neurology and genetics.</gtr:impact><gtr:outcomeId>5450b31b15c980.18653804</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Departmental Seminar Series at Addenbrooke's Hosital (Cambridge)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>008D5AE7-C3B0-4D5C-872A-25CF7F20CEBB</gtr:id><gtr:impact>Invited speaker at Departmental Seminar Series at Addenbrooke's Hospital. Delivered presentation on early onset Parkinson's disease.

Educating and sharing information among health professionals.</gtr:impact><gtr:outcomeId>5450e0a2cd8725.43379416</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Disease Nurse Specialist Association conference (Coventry)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E9FD2C28-46B0-435F-886D-BEC441B9903A</gtr:id><gtr:impact>Presented at the annual Parkinson's Disease Nurse Specialist National two day conference in Coventry. Topics included:
Key Note Speaker - Pain
The Mental Maze
Parkinson's Excellence Network Update
Including underserved and minority groups in Parkinson's (Prof R. Walker)
Dragons Den - Hot topics / Innovations / Hot off the press
Case Presentations - Difficult / Interesting Cases
Things That Go Bump in the night
Neurological Examination
Tip of the Iceberg - Differential Diagnosis
Sticks and Stones - Falls and Fracture Risk</gtr:impact><gtr:outcomeId>56d441c1cbc768.91854943</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Women and Home article: Parkinson's Happens to Young People Too</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ABFEB56-2945-47A4-AB7B-564B57BEA864</gtr:id><gtr:impact>Gave an interview for Women and Home for the article 'Parkinson's Happens To Young People Too', published 10 March 2015. The article covered important issues for early onset Parkinson's, such as diagnosis, causes and symptoms.</gtr:impact><gtr:outcomeId>56d45769b73da8.64779695</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MNDA Patient Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>062501DD-AD9F-47B0-A91B-B91AE3969313</gtr:id><gtr:impact>Lecture at MNDA patient meeting

unknown</gtr:impact><gtr:outcomeId>kp6q52Hfmvu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists Annual Meeting (Harrogate)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32B0EC27-47D8-4265-A9DE-DFF6C7E06E98</gtr:id><gtr:impact>Four day meeting organised by the Association of British Neurologists (ABN) that involved workshops, presentations, training, special interest group discussions and poster presentations. Topics included:
- Audit/quality assurance
- Clinical phenomenology
- Diagnostic investigations
- Commissioning neurology services
- Disease pathophysiology
- Therapeutics
- Case presentations</gtr:impact><gtr:outcomeId>56d45161b80dc9.15032795</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School vist, Henry VIII School, Abergavenny</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>85A78FE0-1DA3-4CB9-9F68-5E44CDFADB52</gtr:id><gtr:impact>Neuroscience day for 6th formers. Viewing of Oliver Sacks's film the Awakenings/ talk/discussion

unknown</gtr:impact><gtr:outcomeId>RFjtSLmsSMQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal College of Psychiatrists - PSP</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4448B91-B94A-4F51-86B3-60F8925279F9</gtr:id><gtr:impact>Invited speaker on PSP to Royal College of Psychiatrists

unknown</gtr:impact><gtr:outcomeId>JihQh1t5oKe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Excellence Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>530F8C04-C48B-46DC-80C6-14D1C2D824EF</gtr:id><gtr:impact>The UK Parkinson's Excellence Network brings together health and social care professionals to transform care for people affected by Parkinson's. The Network will:
- enable professionals to work together for change
- build an expert workforce
- equip professionals to influence services
- strengthen the voice of people affected

The Network offers resources to support service improvement and engage people affected by Parkinson's, comprehensive information about education and training and collaboration opportunities.</gtr:impact><gtr:outcomeId>56d4353cad1275.61171302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.parkinsons.org.uk/professionals/about-excellence-network</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short Course Queen Square - PSP</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ECBAAB4D-FFC5-4499-A514-7AC12474B876</gtr:id><gtr:impact>Lecture to health professsionals on short course

unknown</gtr:impact><gtr:outcomeId>gLGLgNmrXp8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Excellence Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87D9B5E4-7819-44CF-837B-B853647D159C</gtr:id><gtr:impact>Prof Huw Morris presented a talk at the Parkinson's Excellence Network London meeting at the Royal Free Hospital, held on the 28th January 2016. The purpose of this meeting was for the working groups to report back on currently ongoing work and results, as well as identified difficulties and challenges, and to bring the working groups together to discuss further steps. 
Attendees included: Patients, Neurologists, Geriatricians, Parkinson's disease nurse specialists (PDNS), Researchers, Psychologists, Psychiatrists, Speech and Language Therapists (SLT), Occupational Therapists (OT), Physiotherapists (PT), Trainees and a Clinical Commissioner.</gtr:impact><gtr:outcomeId>58c6e8194927d3.99563364</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Barnet Parkinson's patient group meeting (Barnet)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4AD848A8-9E57-449B-9CCA-D556E0050607</gtr:id><gtr:impact>Attended a patient group meeting for Parkinson's patients in the Barnet area. This generated interest in research studies and several patients made contact with the research team to express their interest in being involved in current research studies.</gtr:impact><gtr:outcomeId>56d44d8c5da834.73509143</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Research Syposium CurePSP (California)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>672A83EA-6CC7-4FAC-BA8E-6E2CD0BA22E1</gtr:id><gtr:impact>The focus of this symposium, organised by CurePSP, was 'Unlocking the secrets of brain disease'. Researchers, academics and clinical practitioners presented results and debated on specialised discussion panels, including the topics of:
- Genetics and Epigenetics
- Clinical Trials</gtr:impact><gtr:outcomeId>56d44024036c73.40535379</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MSA Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1D1BF0F5-284A-4CE6-9358-C1F552A98CDA</gtr:id><gtr:impact>Lecture in MSA Workshop

Led to developing MSA network UK</gtr:impact><gtr:outcomeId>pnkmoqRsVcL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society of Medicine: Genetics of Movement Disorders (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D01D163C-56A1-4708-BA7E-43EB72C9BDD1</gtr:id><gtr:impact>The aim of the meeting was to explain the importance and relevance of medical genetics in the management of patient with movement disorders and to enable the recognition of &amp;quot;common&amp;quot; movement disorders by non-movement disorder specialists. Participants learnt to recognise &amp;quot;common&amp;quot; movement disorders, such as tremor, chorea and ataxia and understood the relevance of medical genetics in the aetiopathogenesis of a variety of disorders associated with abnormal movement. Participants were taught to recognise clinical features, symptoms and signs suggesting a genetic cause for patients with movement disorders, and how to distinguish these from other potential causes. Participants learnt to understand the utility, advantages but also potential difficulties of genetic testing in patients with movement disorders.</gtr:impact><gtr:outcomeId>56d456b7539c33.30519723</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Free Hospital Neurosciences meeting (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FC3FEE70-4049-4D61-ADEE-C1A861B62AA8</gtr:id><gtr:impact>Presented a talk at the RFH Neurosciences meeting to trainees and consultants to promote the 100,000 Genomes Project. This successfully generated interest in the research study and increased the number of local referrals for the project.</gtr:impact><gtr:outcomeId>587de0ab879993.19579111</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Disease Society Meetings</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3AAF28C5-4BB4-4259-9F70-1199C5A744D0</gtr:id><gtr:impact>I meet with PDS group members at PDS meetings and provide updates on our research in PD. This includes local (Newport, Bridgend, Bristol, Camarthen, Bronllys) and national (Stratford 2009 - Younger Parkinson's Network Meeting) meetings

We continue to develop an ongoing relationship with the Parkinson's disease society which leads to further referrals (include volunteer patients) for our research</gtr:impact><gtr:outcomeId>A85005A7CE8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PRoBaND investigator meeting 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>889B8C66-8F86-4974-98CE-07555661DA5E</gtr:id><gtr:impact>This meeting with PRoBaND investigators and study teams from across the UK provided the opportunity to discuss analysis plans and present data.</gtr:impact><gtr:outcomeId>587cecb0d75837.72579376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Independent Doctors Federation Spring Symposium (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4BE377E4-E42C-49C5-AA12-2CF37DEEFCD7</gtr:id><gtr:impact>Prof Morris presented a talk at the Independent Doctors Federation Spring Symposium 'Neurology Today and Tomorrow'.</gtr:impact><gtr:outcomeId>587e1407addee9.24425045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK Brain Bank meeting (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>56E19244-9E22-4AC2-97CF-0D7468AEA6E2</gtr:id><gtr:impact>Meeting with Parkinson's UK regarding Brain Banking</gtr:impact><gtr:outcomeId>56d45844775c37.85183153</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BGS - ALS  -Neurodem Cymru</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7A31A9B-F586-4AF1-9B25-71F86E7CF771</gtr:id><gtr:impact>Invited speaker on Chromosome 9 to NEURODEM Cymru event

unknown</gtr:impact><gtr:outcomeId>oMXSg8hbUdr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biomedical Research Advisory Panel (BRAP) meeting Motor Neurone Disease Association (MNDA)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>16D7EF56-5DA7-4AB2-8145-C47710ED9AFE</gtr:id><gtr:impact>This panel of MND research experts, along with Association trustees, discussed research applications in detail. They then decided whether the research is good enough to be funded by the Association and fit within our research strategy.</gtr:impact><gtr:outcomeId>587cf65a185e56.29998493</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society of Physicians in Wales Spring Meeting (Portmeirion)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6DA34CFD-AC32-476B-8A20-8DFB5354B3DB</gtr:id><gtr:impact>Meeting of the Society of Physicians in Wales that included sessions on the future of hospitals commission and impact on working practices, and chief resident programme. Attendees shared and furthered their knowledge of acute and general medicine.</gtr:impact><gtr:outcomeId>56d45261d4f7a3.22120904</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IPDGC meeting (Paris)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ECA52173-1C39-409E-B459-A7CA4429D30B</gtr:id><gtr:impact>Meeting of members in the International Parkinson's Disease Genetics Consortium in Paris.</gtr:impact><gtr:outcomeId>56d4547af35f91.64542802</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with CBD Solutions 2016 (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4A632DF3-49B0-4814-9002-B887BD3CB59D</gtr:id><gtr:impact>Meeting with Cortico Basal Degeneration Solutions in London to plan future activities and present current research progress.</gtr:impact><gtr:outcomeId>587e156adec7f4.06304230</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CurePSP 2016 International Research Symposium (New Jersey)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>18BCB3FA-B2CF-41E6-A721-6ACCFE77456D</gtr:id><gtr:impact>CurePSP conducts an annual International Research Symposium that brings together international investigators to hear about and discuss the latest advances in prime of life neurodegeneration including PSP, CBD, MSA and related diseases. The Symposium highlighted research by CurePSP grantees. The Research Symposium also assisted the CurePSP Scientific Advisory Board (SAB) in identifying work of exceptional promise, which may then be considered for additional funding. Presentations covered: cell biology research, genetics research, clinical trials, diagnostic criteria and therapeutic opportunities.</gtr:impact><gtr:outcomeId>587cf7f4c8e3d8.72077580</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Academy of Neurology Symposium (Berlin)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>99F08DF1-3A54-4E12-9576-6B6A9A3A31CB</gtr:id><gtr:impact>Attended the EAN Neurology Symposium in Berlin which included presentations, teaching courses, hands-on-courses, focused workshops and interactive sessions. Topics included:
- Preclinial neurological diseases
- Expanding fields in neurology
- Modern molecular genetics
- Present and future treatment in movement disorders</gtr:impact><gtr:outcomeId>56d44f11e0d634.23366582</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists Council meeting 2016 (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>25C9BBB8-8A02-4D7D-ACA9-D09339727153</gtr:id><gtr:impact>Prof Morris attended the ABN Council meeting, which included lay trustees and council members.</gtr:impact><gtr:outcomeId>587e166976b3b7.16946854</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queen Square Parkinson's disease and movement disorders course (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7D6A042C-3C9F-4872-B66B-1EF833D2D7EF</gtr:id><gtr:impact>Members of the research team attended the course 'Genetics and cellular mechanisms of Parkinson's disease and Movement Disorders' held at Queen Square. Topics included: current genetics research, bioinformatic analysis, pathological cases, and treatments.</gtr:impact><gtr:outcomeId>587e1876d72a50.79604931</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementias Portfolio Development Group (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3233D02F-4931-46FF-958A-D97B21774BE1</gtr:id><gtr:impact>Participated in the Portfolio Development Group at Parkinson's UK, London.</gtr:impact><gtr:outcomeId>587ddd91d19121.18352024</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia Research Institute meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>06A4A9E6-BAC5-443E-A0A7-99BA3A4B13F4</gtr:id><gtr:impact>Meeting to prepare the Dementia Research Institute bid. This was later successfully granted to UCL. The DRI will assemble the necessary critical mass of world-leading researchers and provide access to cutting edge tools and capabilities in order to:

Accelerate the pace of discovery research to identify new targets for drug development
Develop new approaches for delivering effective clinical trials to targeted patient groups
Attract new partnerships with the biopharmaceutical sector to develop new therapeutics and diagnostics and
Develop and promote strategies for interventions that prevent the development or progression of dementia
Provide new insights and technology-based approaches to delivering more effective care and support to people with dementia and their carers.</gtr:impact><gtr:outcomeId>587e1bb732e989.39266729</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.mrc.ac.uk/about/institutes-units-centres/uk-dementia-research-institute/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hay Festival - What is dementia?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>11FAFBFF-2BB5-4475-BA21-9A5D331B9A34</gtr:id><gtr:impact>Lecture to 400 members of public at Hay Literary Festival

http://www.walesonline.co.uk/news/health-news/2012/06/07/leading-the-fight-against-dementia-in-wales-91466-31133563/</gtr:impact><gtr:outcomeId>Vs526AoCbdT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.walesonline.co.uk/news/health-news/2012/06/07/leading-the-fight-against-dementia-in-wales-91466-31133563/</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Families Project patient meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6A7C7402-BB4A-4B6F-8284-FEF8E76B0B87</gtr:id><gtr:impact>A small panel met with a PD patient to go discuss a draft Participant Information Sheet, receiving helpful feedback and opinions from the patient.

The meeting was very productive and generated positive feedback about the draft information sheet. It also provided helpful feedback which influenced later versions of study material.</gtr:impact><gtr:outcomeId>543fa10cc00ac3.98095331</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar on Corticobasal degeneration - from molecular mechanisms to potential treatment (Stockholm)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D41E9534-9B83-49CF-AC46-1743FAA02A42</gtr:id><gtr:impact>Invited speaker at seminar titled 'Corticobasal degeneration - from molecular mechanisms to potential treatment', organised by Karolinska Institutet Seminars, CBD Solutions.

Sharing information among researchers</gtr:impact><gtr:outcomeId>5450e24b342f42.67687124</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IPDGC meeting (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E974FDD7-883C-4C37-B5E9-3575148F39FF</gtr:id><gtr:impact>Organised and hosted a successful meeting with members of the International Parkinson's Disease Genetics Consortium. Members presented and discussed topics including:
- Clinical data and potential collaboration
- Genotype/phenotype data on progression and head injury
- Data collection - HPO, Genomics England and CDE
- Studies in at-risk cohorts
- Potential research questions, such as progression, age of onset analysis, progression to dementia, familial analysis, pathologically confirmed cases, pathology as a quantitative trait, tremor vs. non-tremor dominant cases, and genotyping in prospective cohorts
- Possible actions</gtr:impact><gtr:outcomeId>56d444989fc3f3.96665767</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LWENC Annual Symposium (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A2186CFB-7C91-4FF3-95B9-87CE1409E16B</gtr:id><gtr:impact>Prof Morris presented a talk and members of the research team attended the symposium titled 'Neurodegeneration: Using genetics to understand pathogenesis and facilitate early diagnosis', hosted by the Leonard Wolfson Experimental Neurology Centre.</gtr:impact><gtr:outcomeId>587e19688b54f6.05556333</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Parkinson's UK Research Conference: 100,000 Genomes Project</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>64B24046-74E1-4C56-99F0-C9DE3CDA52C9</gtr:id><gtr:impact>Our research nurse presented a poster at the Parkinson's UK Research Conference 2016, presenting recruitment and baseline data from the 100,000 Genomes Project.</gtr:impact><gtr:outcomeId>587cf2476b94f9.39987355</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Create a nested CPT resource with the CANDAS biobank using the CANDAS consent to store genetic data from PD-STAT</gtr:description><gtr:fundingOrg>Cure Parkinson's Trust</gtr:fundingOrg><gtr:id>5681E36C-D3D8-48C9-9139-68CA23F60F97</gtr:id><gtr:outcomeId>56d42dec10c926.49524915</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>184000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Autophagic dysfunction in cellular models of inherited MND/FTLD (co-applicant)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>1B64CC53-BF13-4D60-A64D-5DB3FD8A9961</gtr:id><gtr:outcomeId>544fb455c80a60.67022651</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28162</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRN Research Capability Funding - PFP Research Assistant post</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>NIHR Clinical Research Network North Thames</gtr:fundingOrg><gtr:id>B053E340-CD92-4A0C-BF59-8BE7F91EB28D</gtr:id><gtr:outcomeId>56d42e87eba2c9.19196827</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Institutional Strategic Support Fund</gtr:department><gtr:description>Royal Free Parkinson's PPI Research Group</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>52A7C4AE-7B83-4CEF-8CC6-D64559F71430</gtr:id><gtr:outcomeId>56d42b08707d03.45337257</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Filling the genetic gaps-exome sequencing in Parkinson's disease (co-applicant)</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>DC5E2195-827C-4A23-BD4A-C2EF2159F1CA</gtr:id><gtr:outcomeId>CcSYumvagQe</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1498</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Institutional Strategic Support Fund</gtr:department><gtr:description>A participant's guide to user- friendly information in genetic research</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>791E876F-3BB9-4A9E-8ADD-E128297E4321</gtr:id><gtr:outcomeId>56d42a876ea845.11701884</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical and pathological study of chronic traumatic encephalopathy in retired professional soccer players</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>E248A7A2-319C-4D86-9C25-E4CF6462CC42</gtr:id><gtr:outcomeId>56d42ca30ccef2.92908957</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515338</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defining the genetic aetiology of early onset Parkinson's disease</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>04EAA89A-C97F-4BC8-B242-A87A81C4D688</gtr:id><gtr:outcomeId>AwoGrq763KQ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228208</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sara Koe Research Fellowship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>188A7E86-A79F-4E33-A7D1-33E28CB7F160</gtr:id><gtr:outcomeId>56d4283f61dc42.05490592</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>305000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Registry and Longitudinal Study of Cortico-Basal Syndrome</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>CBD Solutions</gtr:fundingOrg><gtr:id>735C0EA0-532E-46FA-AA4C-6311108AA7F8</gtr:id><gtr:outcomeId>56d42902143872.29917046</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48972</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Parkinson's Families Pilot Project - Genomics England Study</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:fundingRef>K-1501</gtr:fundingRef><gtr:id>5C6BCF38-71EC-4B4D-9EA3-8916F0766AC7</gtr:id><gtr:outcomeId>58c6e54a2b9682.04841136</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A Longitudinal Biomarker Study of Sports Related Head Injury and Outcomes</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>818AE530-6FFF-449A-BA32-FCBADC9D49F0</gtr:id><gtr:outcomeId>56d42d20c64d61.97515557</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>294808</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A Longitudinal Clinical and Biomarker Study of Progressive Supranuclear Palsy and Cortico-Basal Syndrome</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>7E1171CA-8E8F-477D-9532-3805A0B5BACB</gtr:id><gtr:outcomeId>56d42784010728.83505350</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>Strategic Biomarkers Initiative Project</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>60FC2EDE-E28B-41B9-B248-7F88E4C80B9E</gtr:id><gtr:outcomeId>56d42b9940dd16.61889293</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of common DNA variants in Parkinson's disease (Wellcome Trust Case Control Consortium 2)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C59EEDE9-D443-42FD-BAF7-989F42A1D81A</gtr:id><gtr:outcomeId>642D43090FA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Parkinson's repository of bio samples and network datasets: PRoBaND</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>08627A03-F711-4EF0-8090-5B96AFA0B983</gtr:id><gtr:outcomeId>UbPcRxQ1hJ1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39652</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Capability Funding - PSP Study Coordinator post</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>NIHR Clinical Research Network North Thames</gtr:fundingOrg><gtr:id>C09BB587-2F21-4161-8FEF-6A9AE438CD7A</gtr:id><gtr:outcomeId>56d42f675db7f0.38750852</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>184697</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of CSF biobank and CSF biomarkers for PSP</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>55C591BF-43FD-4FEA-9477-BF47B9C21109</gtr:id><gtr:outcomeId>56d427e34408c9.22372821</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>H. R. M is a co-applicant on a patent application related to C9ORF72 - Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140). 

1 in 50,000 people have motor neuron disease (MND). Amyotrophic lateral sclerosis (ALS) is a form of MND characterized by the death of motor neurons in the brain, brainstem and spinal cord. This leads to wasting in the limbs and progressive paralysis, and there are no effective therapies - it is fatal due to eventual respiratory failure, typically two to three years after the onset of symptoms. Around 5% of ALS cases are familial (inherited). Frontotemporal dementia (FTD) is a relatively common cause of dementia in younger patients but is overall less common than Alzheimer disease or Cortical Lewy body disease. Symptoms vary but can include behavioural and personality changes, problems with language skills and inability to plan or organize complex tasks. There is evidence to suggest that there is an overlap with these ALS and FTD as symptoms of both conditions can occur in the same patient, in the same families and as alternative presentations of pathogenic C9ORF72 (OMIM 614260) mutations.</gtr:description><gtr:grantRef>G1100643</gtr:grantRef><gtr:id>A87C9AB9-F806-4EB2-B2EC-435A67BE328B</gtr:id><gtr:impact>The recent discovery of large 6bp repeat expansions in chromosome 9 open reading frame 72 (C9ORF72 - chromosome location 9p21) is diagnostic of familial ALS and FTD, and may also be used as a predictive test for at-risk familial members [Ref. Neuron 2011, 72(2); 257-68]. Mutations in MAPT, GRN, TARDP and UBQLN2 genes, among others, may cause similar clinical syndromes.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56d45de6a03227.97451199</gtr:outcomeId><gtr:patentId>PCT/GB2012/052140</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>C9PORF72: Method for Diagnosing a Neurodegenerative Disease</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIHR Clinical Research Network North Thames Specialty Lead</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5267ACAD-649B-4862-89CC-49CB952A1ACE</gtr:id><gtr:impact>As the NIHR CRN specialty lead for Neurodegeneration, Prof Huw Morris is involved in influencing research decisions and activity.</gtr:impact><gtr:outcomeId>587cfcbd25dce6.68117450</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Honorary Medical Advisor with expertise in Parkinson's disease for Secretary of State for Transport's Panel on Driving and Disorders of the Nervous System (DVLA)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>46120F4D-5919-44C3-BDFD-6930EA623E17</gtr:id><gtr:outcomeId>5450d31e939953.45817423</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Driver and Vehicle Licensing Agency Medical Advisory Panel 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0102E00A-20EA-4ED5-8A52-E1AF34BC809D</gtr:id><gtr:outcomeId>587e1cba5a6459.84459510</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>This is a within-subject, controlled open-label study seeking to determine if EPI-589 can alter the biochemical signature of PD as assessed by peripheral blood and brain imaging biomarkers. Data will also be collected on disease-relevant clinical measures will be collected. This project is sponsored and funded by Edison Pharmaceuticals.</gtr:description><gtr:id>C329CEBB-4C24-48F7-8619-5B30ECB1B06D</gtr:id><gtr:impact>The safety trial is still ongoing.</gtr:impact><gtr:outcomeId>587e1fd54f2062.87975577</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Safety and Biomarker Study of EPI-589 in Parkinson's Disease</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>http://www.hra.nhs.uk/news/research-summaries/safety-and-biomarker-study-with-epi-589-in-parkinsons-disease/</gtr:url><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>http://www.wales.nhs.uk/sites3/documents/525/MI-MGN-ALS-FTD_21.pdf</gtr:description><gtr:id>BC84E135-357E-4C8A-A1B4-567A9E084C1D</gtr:id><gtr:impact>unknown</gtr:impact><gtr:outcomeId>dAQfwsuB5MB</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>C9orf72</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.wales.nhs.uk/sites3/documents/525/MI-MGN-ALS-FTD_21.pdf</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Genie is an online database that manages recruitment, data collection and submission to Genomics England</gtr:description><gtr:id>9E95A443-A518-48F1-8DD0-02EAC416A7DA</gtr:id><gtr:impact>Ease of data collection and search</gtr:impact><gtr:outcomeId>587ce2a29e8260.45530197</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Genie Genomics England database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Records of patient details, consultant details, clinical summary and family history</gtr:description><gtr:id>D3E6510C-513D-45AD-AF59-087BF2869439</gtr:id><gtr:impact>Enables researchers to store important patient details for large numbers of study participants</gtr:impact><gtr:outcomeId>543fb3677c3ee3.22117200</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CANDAS/WPG database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Research Electronic Data Capture (REDCap) is a secure web application for building and managing online surveys and databases. Databases have been set up for current projects in the research team, including the Parkinson's Families Project, PROSPECT and the European Registry of CBD. These databases allow for data entry by both researchers and participants around the UK online through a secure web connection, and could facilitate easy data sharing in the future to collaborators. The databases hold large amounts of clinical and phenotypic data from research participants.</gtr:description><gtr:id>1D886911-D9F1-4782-BE95-FC6D84E93237</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>56d45c8a0d52b4.69689644</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>REDCap databases</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://project-redcap.org/</gtr:url></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Collection of DNA samples and Peripheral Blood Lymphocytes for PD patients</gtr:description><gtr:id>3DAB9D18-F027-4CD3-BDB6-3F585B09C337</gtr:id><gtr:impact>Use in gene mapping studies</gtr:impact><gtr:outcomeId>FyiNuQ3CtZY</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Parkinson's disease - biological collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>88257255-CF53-4947-864D-6CEA2B75B8BC</gtr:id><gtr:title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11f6020b757bd989fc204657e8aabfac"><gtr:id>11f6020b757bd989fc204657e8aabfac</gtr:id><gtr:otherNames>Waite AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54204ac58fb528.73009197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC584C5E-BD54-4232-8505-0F534527B263</gtr:id><gtr:title>Is the MC1R variant p.R160W associated with Parkinson's?</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56d412c69e6d89.98398091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>999A1E71-C32F-4012-B039-3B74A7B3F1AA</gtr:id><gtr:title>CHCHD2 and Parkinson's disease</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2799c24a29f08ff3d5a71022d279d8b8"><gtr:id>2799c24a29f08ff3d5a71022d279d8b8</gtr:id><gtr:otherNames>Jansen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d415f47c6852.98712086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60363B7D-8EDA-40EF-BAEE-6F5FADCC99EF</gtr:id><gtr:title>NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d416a2b98647.71325034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F35B5DD-C9EE-46C1-9EC9-BC242F8732FE</gtr:id><gtr:title>Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a122567e3854ed708543b4c753c9fc8e"><gtr:id>a122567e3854ed708543b4c753c9fc8e</gtr:id><gtr:otherNames>Weil RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5a995f4a489da0.58673692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9943082F-2C92-4408-9429-8447C8B08A2E</gtr:id><gtr:title>Parkinson's disease: chameleons and mimics.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/943f72cd687d86f716c47043bea277d9"><gtr:id>943f72cd687d86f716c47043bea277d9</gtr:id><gtr:otherNames>Ali K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>5450e530c24992.41794555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>960F47DD-03D7-4CEE-86F9-F5C6989E74B0</gtr:id><gtr:title>Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>587cde457fa8b5.91908350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59094E58-9DF5-4F79-8BA4-060DB5353AB1</gtr:id><gtr:title>NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c548daa91b19b3ab5594f4482ec73e2"><gtr:id>5c548daa91b19b3ab5594f4482ec73e2</gtr:id><gtr:otherNames>Blauwendraat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5a2fdbd4ce5883.22406133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F57C52C-0812-44C7-9468-ACCED2D0A638</gtr:id><gtr:title>Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d415f52a9902.08476043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E23DA5-A9D2-4B04-AEEF-B29FACF6A8CA</gtr:id><gtr:title>Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d266192c3f1da4e2a8ec1b2347453e58"><gtr:id>d266192c3f1da4e2a8ec1b2347453e58</gtr:id><gtr:otherNames>Lesage S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>587cde462ea757.33495023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12AECA72-E0CA-48BA-A733-2294405A9768</gtr:id><gtr:title>Genetic risk and age in Parkinson's disease: Continuum not stratum.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5675e0ed2be74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16158B19-10AC-4945-B9A3-0F9DC0E3B157</gtr:id><gtr:title>Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d14c3a9646f0da9792d2b4276c13d04a"><gtr:id>d14c3a9646f0da9792d2b4276c13d04a</gtr:id><gtr:otherNames>Moskvina V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_12468_28_23921447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>336D28FB-FC00-4B0B-901F-B63BD78CCB95</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56d41939198284.30050681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F198B988-D367-4026-8EFD-0FC4C324FD30</gtr:id><gtr:title>Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f2f0764dd1bcc79b805b94497f0c43"><gtr:id>73f2f0764dd1bcc79b805b94497f0c43</gtr:id><gtr:otherNames>Sim?n-S?nchez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12468_28_22427796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01BDD411-653E-4208-A33C-9D24EA7B7F37</gtr:id><gtr:title>Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12468_28_23881105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3324428A-D7A2-4706-A951-754F7ADAAD3F</gtr:id><gtr:title>The frequency of spinocerebellar ataxia type 23 in a UK population.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c4d0dfc03600335329f8ac761e66b0"><gtr:id>41c4d0dfc03600335329f8ac761e66b0</gtr:id><gtr:otherNames>Fawcett K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12468_28_23108490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2170DC93-C231-41DD-8586-CB233BB682D3</gtr:id><gtr:title>Polygenic risk of Parkinson disease is correlated with disease age at onset.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>doi_55f984984760c94b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A9A2BAD-DCEB-4964-9647-CD051D363BFE</gtr:id><gtr:title>Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc5b5762113644a4bc53ab2a81094d8"><gtr:id>ccc5b5762113644a4bc53ab2a81094d8</gtr:id><gtr:otherNames>Magdalinou NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>5a58c08f8aa976.88340565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD514149-693A-4CDB-AB79-2C7613EC05B4</gtr:id><gtr:title>Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8db82102989598335512733b4a848e6"><gtr:id>e8db82102989598335512733b4a848e6</gtr:id><gtr:otherNames>Norman BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>5a360d73d16c17.66988611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51F5CA7A-38DC-4FB9-B546-9562C70B1D60</gtr:id><gtr:title>Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/837b2dd55fd727fb4dddd9498f8bd733"><gtr:id>837b2dd55fd727fb4dddd9498f8bd733</gtr:id><gtr:otherNames>Lawton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>5a58c090b72856.60366957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2C7A754-CE01-491E-B382-007FCED92ED4</gtr:id><gtr:title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>5675eab514747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2B91846-E36D-4771-9515-AE1C389A590B</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>587cde45eeec13.64191223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EEC94FA-4521-4AC1-AF51-7D834DAC9D06</gtr:id><gtr:title>Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12468_28_23645593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CBA175A-38D8-49E3-9534-FF7659101FF6</gtr:id><gtr:title>SGCZ mutations are unlikely to be associated with myoclonus dystonia.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>54205a70a49d58.71354598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BDDAB3F-1BE1-4E53-80D8-6A77946C7582</gtr:id><gtr:title>Visual dysfunction in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a122567e3854ed708543b4c753c9fc8e"><gtr:id>a122567e3854ed708543b4c753c9fc8e</gtr:id><gtr:otherNames>Weil RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>588252b343c912.74983379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91091FB5-B860-4610-9454-F421EEFC936F</gtr:id><gtr:title>Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of Parkinson's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc3d325cdc9f5b30d594bd43639eab9f"><gtr:id>cc3d325cdc9f5b30d594bd43639eab9f</gtr:id><gtr:otherNames>Jenner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1877-7171</gtr:issn><gtr:outcomeId>pm_12468_28_23938306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44A98BD5-DB2B-4878-A024-6E75A10D41E0</gtr:id><gtr:title>Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/294db2869edeb2078cb0efde58ad2c97"><gtr:id>294db2869edeb2078cb0efde58ad2c97</gtr:id><gtr:otherNames>Kilarski LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_12468_28_22956510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>875F0866-399A-4F0C-B346-57F493EC450B</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56d418170bcec5.53199832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C7403A4-7170-49E2-B420-D55DBD2092AE</gtr:id><gtr:title>Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95c25a60693a992681a42b54c91bff9e"><gtr:id>95c25a60693a992681a42b54c91bff9e</gtr:id><gtr:otherNames>Dong J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54204cd1694585.09340685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B64B4D-94CF-42ED-A456-C94D22CAA895</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease</gtr:title><gtr:parentPublicationTitle>Human Molecular Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b463e3b0fd8b6a0fbd4f7e43ecff6a2b"><gtr:id>b463e3b0fd8b6a0fbd4f7e43ecff6a2b</gtr:id><gtr:otherNames>Keller M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56d4198f568456.87011273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDA3A543-B155-4AC5-8B19-8DA5A6745095</gtr:id><gtr:title>Variation in tau isoform expression in different brain regions and disease states.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12468_28_23428180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E1FDB6D-A3FE-4A75-BEA1-97F3FC557596</gtr:id><gtr:title>Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>588251e1a4a0c5.01494252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF786F5-753D-450C-9AAE-4875D48978B9</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>542043b5118127.22967798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>841E931B-7854-4ED1-8DBC-D39B7DA1588A</gtr:id><gtr:title>Defining neurodegeneration on Guam by targeted genomic sequencing.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14f21c098907802100e4488ee4bed78c"><gtr:id>14f21c098907802100e4488ee4bed78c</gtr:id><gtr:otherNames>Steele JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56d415f4a269e7.45780545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6973D0BF-194E-4FA2-8D1B-5AA260DAD156</gtr:id><gtr:title>Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d633de923aea18df03c8589daadc941"><gtr:id>6d633de923aea18df03c8589daadc941</gtr:id><gtr:otherNames>Pichler I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_12468_28_23750121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF031CEA-B305-46A2-9EAC-69FCE182B335</gtr:id><gtr:title>Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>585d34d989a982.76900728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B54C5D9-C119-46D4-95CA-5B6541DC3579</gtr:id><gtr:title>Psychiatric disorders, myoclonus dystonia and SGCE: an international study.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>56d412c6d3ead3.91752527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF26D94C-7371-40A7-B68C-3AF555842213</gtr:id><gtr:title>SGCE mutations cause psychiatric disorders: clinical and genetic characterization.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12468_28_23365103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C9DC717-6B65-462E-B9F0-A987FDFBB69D</gtr:id><gtr:title>Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aa7d68da72e3547436051956af0d4cb"><gtr:id>1aa7d68da72e3547436051956af0d4cb</gtr:id><gtr:otherNames>Malek N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>5a58c08fc65040.35657700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>805555C6-BF3B-4871-A68E-99A8BCD6E724</gtr:id><gtr:title>Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e92699e66f262cd182ee6581ab96aae"><gtr:id>5e92699e66f262cd182ee6581ab96aae</gtr:id><gtr:otherNames>H?glinger GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5a58c08e35b118.65583765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E552101-50D8-4D7E-A974-AD7EB80A4A82</gtr:id><gtr:title>Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>54204336c1c965.01421323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>648D48FB-46D6-4360-BD04-CC205CF9F6C2</gtr:id><gtr:title>SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56d4187543e593.46982310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41278F62-4005-4146-993D-538D15219461</gtr:id><gtr:title>Tau acts as an independent genetic risk factor in pathologically proven PD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80bdbfdd0b1d93ff7f53295d25d425e7"><gtr:id>80bdbfdd0b1d93ff7f53295d25d425e7</gtr:id><gtr:otherNames>Charlesworth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12468_28_22221882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0912822-F35F-42EA-A5EA-2D3A796E0EC6</gtr:id><gtr:title>Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00d9c86209b5f42f6478e01063159488"><gtr:id>00d9c86209b5f42f6478e01063159488</gtr:id><gtr:otherNames>Witoelar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5a58c08f4952a7.70851543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88FFC4F3-5D5A-4425-BB88-C1694D97AF06</gtr:id><gtr:title>Genetic comorbidities in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12468_28_24057672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A480EE2-A6DF-47A4-B395-FBB520033BD2</gtr:id><gtr:title>Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5a58c08f135318.89135650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>610DA963-78F4-4969-9D38-B33E021D1D7C</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed587de899b30ad5f3dce3fc99e9d0a"><gtr:id>5ed587de899b30ad5f3dce3fc99e9d0a</gtr:id><gtr:otherNames>Keller MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12468_28_22892372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1517595-350A-4D77-A6AE-D1BAE515309E</gtr:id><gtr:title>Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aac30b01b744525ffc7d06e70f2732d7"><gtr:id>aac30b01b744525ffc7d06e70f2732d7</gtr:id><gtr:otherNames>Jansen IE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a58c08ea3dac0.10675529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B7B5D1B-D3C3-45D1-8D28-D9D96F8AAA2A</gtr:id><gtr:title>Recent advances in Parkinson's disease genetics.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfdbbd778d82415d550b65bbacb4f286"><gtr:id>cfdbbd778d82415d550b65bbacb4f286</gtr:id><gtr:otherNames>Lubbe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_540e17be17b9d6288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14E52B64-0462-4C8D-8104-1E02C0997E1A</gtr:id><gtr:title>Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56d415f5048946.10702596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>836CFC80-66B4-4AEB-B1DB-5AEDDCDE97C1</gtr:id><gtr:title>Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d9b30d099d6baedd937038ef4d2f899"><gtr:id>9d9b30d099d6baedd937038ef4d2f899</gtr:id><gtr:otherNames>Beilina A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54204df635f881.04599019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FEFEA8B-79EF-4792-A196-843C614C689C</gtr:id><gtr:title>C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cff10bee5d72bc02ba737264f5aea808"><gtr:id>cff10bee5d72bc02ba737264f5aea808</gtr:id><gtr:otherNames>O'Dowd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_12468_28_22807188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7251DC15-4B17-4EDE-B959-E01290ADC7E2</gtr:id><gtr:title>A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56d412c7072a79.59449078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFB6C6C5-4C43-46AE-A65C-A38C3C39982E</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849847697f31</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100643</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>